𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Predominant occurrence of somatic mutations of the NF2 gene in meningiomas and schwannomas

✍ Scribed by P. Mérel; K. Hoang-Xuan; M. Sanson; A. Moreau-Aubry; E. K. Bijlsma; C. Lazaro; J. P. Moisan; F. Resche; I. Nishisho; X. Estivill; J. Y. Delattre; M. Poisson; C. Theillet; T. Hulsebos; O. Delattre; G. Thomas

Publisher
John Wiley and Sons
Year
1995
Tongue
English
Weight
469 KB
Volume
13
Category
Article
ISSN
1045-2257

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

The NF2 gene is a putative tumor‐suppressor gene that, when it is altered in the germline, causes neurofibromatosis type 2, a tumor‐susceptibility disease that mainly predisposes to schwannomas and meningiomas. The recent isolation of the NF2 gene on chromosome 22 allows the identification of somatic mutations in human tumors. We have searched for mutations of the NF2 gene in 331 primary human tumors using a screening method based on denaturing gradient gel electrophoresis, which allows the detection of mutations in 95% of the coding sequence. Mutations were observed in 17 of 57 meningiomas and in 30 of 89 schwannomas. No mutations were observed for 17 ependymomas, 70 gliomas, 23 primary melanomas, 24 pheochromocytomas, 15 neuroblastomas, 6 medulloblastomas, 15 colon cancers, and 15 breast cancers. All meningiomas and one‐half of the schwannomas with identified NF2 mutations demonstrated chromosome 22 allelic losses. We conclude that the involvement of the NF2 gene in human tumorigenesis may be restricted to schwannomas and meningiomas, where it is frequently inactivated by a two‐hit process. © 1995 Wiley‐Liss, Inc.

📜 SIMILAR VOLUMES

Genetic and epigenetic alteration of the
Genetic and epigenetic alteration of the NF2 gene in sporadic meningiomas
✍ Jesus Lomas; M. Josefa Bello; Dolores Arjona; M. Eva Alonso; Victor Martinez-Gle 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 157 KB 👁 1 views

## Abstract The role of the __NF2__ gene in the development of meningiomas has recently been documented; inactivating mutations plus allelic loss at 22q, the site of this gene (at 22q12), have been identified in both sporadic and neurofibromatosis type 2–associated tumors. Although epigenetic inact

Screening for large mutations of the NF2
Screening for large mutations of the NF2 gene
✍ Lan Kluwe; Anders O.H. Nygren; Abdellatif Errami; Bianca Heinrich; Cordula Matth 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 230 KB 👁 1 views

## Abstract Neurofibromatosis 2 (NF2) is a genetic disorder caused by mutational inactivation of the __NF2__ gene and is characterized by bilateral vestibular schwannomas, spinal tumors, and other benign tumors of the nervous system. Previously, we found intragenic __NF2__ mutations in 99 of 188 un

The distribution of constitutional and s
The distribution of constitutional and somatic mutations in the neurofibromatosis 2 gene
✍ Michael E. Baser 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 224 KB 👁 1 views

Communicated by Marc S. Greenblatt Constitutional heterozygous inactivating mutations in the neurofibromatosis 2 (NF2) tumor suppressor gene cause the autosomal dominant disease NF2, and biallelic inactivating somatic NF2 mutations are found in a high proportion of unilateral sporadic vestibular sch

Characterization of the somatic mutation
Characterization of the somatic mutational spectrum of the neurofibromatosis type 1 (NF1) gene in neurofibromatosis patients with benign and malignant tumors
✍ Meena Upadhyaya; Song Han; Claudia Consoli; Elisa Majounie; Martin Horan; Nick S 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 307 KB 👁 1 views

## Communicated by Haig H. Kazazian One of the main features of neurofibromatosis type 1 (NF1) is benign neurofibromas, 10-20% of which become transformed into malignant peripheral nerve sheath tumors (MPNSTs). The molecular basis of NF1 tumorigenesis is, however, still unclear. Ninety-one tumors